Causal analysis of absolute and relative risk reductions

Abstract excerpt

<p>Any new medical innovation must first prove its benefits with reliable evidence from clinical trials. Evidence is frequently expressed using two metrics, summarizing treatment benefits based on either absolute risk reductions (ARRs) or relative risk reductions (RRRs). While both metrics are derived from the same data (e.g., observed frequencies of a disease in a treatment and control group), they implement conc...

Topics

Open a Topic to create a Post that cites this publication.

• Clinical Trials as Topic
• Confidence Intervals
• Evidence-Based Medicine
• Odds Ratio
• Protein Precursors
• Proteolipids
• Respiratory Distress Syndrome
• Risk Assessment

Identifiers and source

Literature Corpus work

4d6d174a-0506-528c-aa37-ee0e2906752a

DOI

10.31234/osf.io/j98vt